Zero cure dengue fever? Hyundai Bioscience's 'Jefti' makes global debut at IDWeek in US
Predicted impact: Low
Conference presentation of antiviral trial plan is early-stage and routine.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.